Share This Article

Facebook LinkedIn
Twitter Reddit
Print Email
Pinterest Gmail
Yahoo
Money Morning
×
  • Invest
    • Best Stocks to Buy
    • Stock Forecasts
    • Stocks to Sell Now
    • Stock Market Predictions
    • Technology Stocks
    • Best REITs to Buy Now
    • IPO Stocks
    • Penny Stocks
    • Dividend Stocks
    • Cryptocurrencies
    • Cannabis Investing
    • Angel Investing
  • Trade
    • How to Trade Options
    • Best Trades to Make Now
    • Options Trading Strategies
    • Weekly Trade Recommendations
  • Retire
    • Income Investing Guide
    • Retirement Articles
  • More
    • Money Morning LIVE
    • Special Investing Reports
    • Our ELetters
    • Our Premium Services
    • Videos
    • Meet Our Experts
    • Profit Academy
Login My Member Benefits Archives Research Your Team About Us FAQ
  • Invest
    • Best Stocks to Buy
    • Stock Forecasts
    • Stocks to Sell Now
    • Stock Market Predictions
    • Technology Stocks
    • Best REITs to Buy Now
    • IPO Stocks
    • Penny Stocks
    • Dividend Stocks
    • Cryptocurrencies
    • Cannabis Investing
    • Angel Investing
    ×
  • Trade
    • How to Trade Options
    • Best Trades to Make Now
    • Options Trading Strategies
    • Weekly Trade Recommendations
    ×
  • Retire
    • Income Investing Guide
    • Retirement Articles
    ×
  • More
    • Money Morning LIVE
    • Special Investing Reports
    • Our ELetters
    • Our Premium Services
    • Videos
    • Meet Our Experts
    • Profit Academy
    ×
  • Subscribe
Enter stock ticker or keyword
×
5 Ways to Beat the Fed (and Crush Inflation)

Email this Article

Send with mail | ahoo instead.
Required Needs to be a valid email
Required Needs to be a valid email
Why Indian Startups Are Targeting This New $5 Billion Market
https://mney.co/2p0qaqr
Required Please enter the correct value.
Twitter
Stocks: BAYRY, CHD, MRK, PFE, TEVA

Why Indian Startups Are Targeting This New $5 Billion Market

By Jack Delaney, Sr. Cannabis Editor, Money Morning • April 20, 2017

Start the conversation

Comment on This Story Click here to cancel reply.

Or to contact Money Morning Customer Service, click here.

Your email address will not be published. Required fields are marked *

Some HTML is OK

Right now, there's a billion-dollar profit opportunity big pharma companies are completely ignoring: reversible male contraceptives. Bloomberg projects this form of contraceptive could cut into half of the $10 billion global female contraceptive market.

And while big pharma ignores this opportunity, Indian startups are seizing this potential $5 billion market.

Indian startups

All the way back in 1978, biomedical engineer Sujoy Guha invented a sperm-zapping gel. The treatment is 98% effective, and the entire procedure (including injection) takes as little as 15 minutes.

One patient reportedly walked 1.6 miles back to his home after the procedure, and he was also back at work within two days.

While recovery time is different for each patient, vasectomies generally have a longer recuperation period. According to Vasectomy.com, most men can return to work two or three days after an operation and can resume normal physical activity within a week. There are an estimated 540 men who had the new procedure in India.

As you can see in the accompanying chart, injectable birth control was among the lowest percentage of unintended pregnancies through contraceptive methods as of 2014.

 Statistic: Percentage of unintended pregnancies among women using select contraceptive methods as of 2014* | Statista

While this could revolutionize the industry and generate billions, big pharma companies are choosing to ignore this emerging market...

Big Pharma Won't Invest in New Drug Market in India

Pfizer Inc. (NYSE: PFE) and Merck & Co. Inc. (NYSE: MRK) have reportedly said it isn't an "area of active research." Bayer AG (OTCMKTS ADR: BAYRY), which bought a company that studied a male birth control pill in the 1990s, stopped research and development on male fertility control in 2006.

With the big drugmakers not interested, you may be wondering why the inventor of the treatment hasn't gone out on his own to dominate this billion-dollar opportunity.

He hasn't because it reportedly costs tens of millions of dollars to have birth control approved, according to Bloomberg.

Trending: Big Pharma's Biggest Enemy Is... Apple?

However, Guha has licensed the technology to a U.S. nonprofit to help establish a market outside of India. The nonprofit plans to manufacture and distribute its own version of the treatment called Vasalgel.

It will cost between $10 and $12 for patients in low- and middle-income countries, and between $400 and $600 for patients in wealthier countries.

This will help build a market across the globe, but we're still keeping our eyes on the treatment and its founder in India. That's because the creator of this reversible male contraceptive just created a startup to develop mass production of the gel.

And if he's successful, this could be one of the hottest startup companies in India and the next big profit opportunity for investors...

Indian Startup News: This Company Could Dominate a New $5 Billion Industry

Join the conversation. Click here to jump to comments…

Login
guest
guest
0 Comments
Inline Feedbacks
View all comments
LIVE
Visit Money Morning Live


Latest News

January 19, 2023 • By Money Morning Stock Research Team

These Stocks Could Go To $0

January 9, 2023 • By Money Morning Stock Research Team

The Government Is Pouring $391 Billion Into These Stocks - Buy Now

December 27, 2022 • By Money Morning Staff Reports

6 IPOs in 2023 You Can’t Afford to Miss
Trending Stories
ABOUT MONEY MORNING

Money Morning gives you access to a team of market experts with more than 250 years of combined investing experience – for free. Our experts – who have appeared on FOXBusiness, CNBC, NPR, and BloombergTV – deliver daily investing tips and stock picks, provide analysis with actions to take, and answer your biggest market questions. Our goal is to help our millions of e-newsletter subscribers and Moneymorning.com visitors become smarter, more confident investors.

QUICK LINKS
About Us COVID-19 Announcements How Money Morning Works FAQs Contact Us Search Article Archive Forgot Username/Password Archives Profit Academy Research Your Team Videos Text Messaging Terms of Use
FREE NEWSLETTERS
Total Wealth Research Power Profit Trades Profit Takeover This Is VWAP Penny Hawk Trading Today Midday Momentum Pump Up the Close
PREMIUM SERVICES
Money Map Press Home Money Map Report Fast Fortune Club Weekly Cash Clock Night Trader Microcurrency Trader Hyperdrive Portfolio Rocket Wealth Initiative Extreme Profit Hunters Profit Revolution Warlock's World Quantum Data Profits Live Trading Alliance Trade The Close Inside Money Trader Expiration Trader Vega Burst Trader Flashpoint Trader Darknet Hyper Momentum Trader Alpha Accelerators

© 2023 Money Morning All Rights Reserved. Protected by copyright of the United States and international treaties. Any reproduction, copying, or redistribution (electronic or otherwise, including the world wide web), of content from this webpage, in whole or in part, is strictly prohibited without the express written permission of Money Morning.

Address: 1125 N Charles St. | Baltimore, MD, 21201 | USA | Phone: 888.384.8339 | Disclaimer | Sitemap | Privacy Policy | Whitelist Us | Do Not Sell or Share My Personal Information

wpDiscuz